348 related articles for article (PubMed ID: 15493113)
41. Could uric acid have a role in acute renal failure?
Ejaz AA; Mu W; Kang DH; Roncal C; Sautin YY; Henderson G; Tabah-Fisch I; Keller B; Beaver TM; Nakagawa T; Johnson RJ
Clin J Am Soc Nephrol; 2007 Jan; 2(1):16-21. PubMed ID: 17699382
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of hyperuricemia and its association with antihypertensive treatment in hypertensive patients in Taiwan.
Lin CS; Lee WL; Hung YJ; Lee DY; Chen KF; Chi WC; Chang SC
Int J Cardiol; 2012 Apr; 156(1):41-6. PubMed ID: 21095025
[TBL] [Abstract][Full Text] [Related]
43. [The pleiotropic effects of losartan--the importance of decreasing uric acid level].
Csiky B; Markó L; Mohás M; Cseh J; Mikolás E; Szíjártó I; Wittmann I
Lege Artis Med; 2008 Oct; 18(10):663-6. PubMed ID: 19227608
[TBL] [Abstract][Full Text] [Related]
44. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
[TBL] [Abstract][Full Text] [Related]
45. The serum uric acid and related cardiovascular risk factors in south Taiwan.
Huang CC; Peng MC; Tsai WC; Chang YY; Chen WH; Chen SS; Liu JS
Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):259-64. PubMed ID: 15906680
[TBL] [Abstract][Full Text] [Related]
46. The role of hyperuricemia in vascular disorders.
Edwards NL
Curr Opin Rheumatol; 2009 Mar; 21(2):132-7. PubMed ID: 19339923
[TBL] [Abstract][Full Text] [Related]
47. The role of hyperuricemia and gout in kidney and cardiovascular disease.
Edwards NL
Cleve Clin J Med; 2008 Jul; 75 Suppl 5():S13-6. PubMed ID: 18822470
[TBL] [Abstract][Full Text] [Related]
48. Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study).
Brodov Y; Behar S; Boyko V; Chouraqui P
Am J Cardiol; 2010 Dec; 106(12):1717-20. PubMed ID: 21126615
[TBL] [Abstract][Full Text] [Related]
49. Management of asymptomatic hyperuricemia.
Duffy WB; Senekjian HO; Knight TF; Weinman EJ
JAMA; 1981 Nov; 246(19):2215-6. PubMed ID: 7289015
[TBL] [Abstract][Full Text] [Related]
50. New insights into uric acid effects on the progression and prognosis of chronic kidney disease.
Filiopoulos V; Hadjiyannakos D; Vlassopoulos D
Ren Fail; 2012; 34(4):510-20. PubMed ID: 22260409
[TBL] [Abstract][Full Text] [Related]
51. Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome.
Kanbay A; Inonu H; Solak Y; Erden A; Uslu E; Yuksel SA; Ozturk MA; McFann K; Johnson RJ; Kanbay M
Eur J Intern Med; 2014 Jun; 25(5):471-6. PubMed ID: 24793835
[TBL] [Abstract][Full Text] [Related]
52. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia.
Cuspidi C; Valerio C; Sala C; Meani S; Esposito A; Zanchetti A; Mancia G
Am J Hypertens; 2007 Jun; 20(6):678-85. PubMed ID: 17531928
[TBL] [Abstract][Full Text] [Related]
53. Uric acid and cardiovascular risk: What genes can say.
Kei A; Koutsouka F; Makri A; Elisaf M
Int J Clin Pract; 2018 Jan; 72(1):. PubMed ID: 29250870
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
Zhu X; Chen J; Han F; Cheng M; Xu L; Zhang L; Ding X; Le Y
Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377
[TBL] [Abstract][Full Text] [Related]
55. Impact of lower achieved blood pressure on outcomes in hypertensive patients.
Okin PM; Hille DA; Kjeldsen SE; Dahlöf B; Devereux RB
J Hypertens; 2012 Apr; 30(4):802-10; discussion 810. PubMed ID: 22343536
[TBL] [Abstract][Full Text] [Related]
56. The role of uric acid in the pathogenesis of human cardiovascular disease.
Kanbay M; Segal M; Afsar B; Kang DH; Rodriguez-Iturbe B; Johnson RJ
Heart; 2013 Jun; 99(11):759-66. PubMed ID: 23343689
[TBL] [Abstract][Full Text] [Related]
57. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
[TBL] [Abstract][Full Text] [Related]
58. [Impact of serum uric acid level on the cardiovascular system as a risk factor].
Hisatome I
Nihon Yakurigaku Zasshi; 2010 Dec; 136(6):325-9. PubMed ID: 21139282
[No Abstract] [Full Text] [Related]
59. Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertension.
Díez J
Clin Ther; 2006 Jun; 28(6):832-48. PubMed ID: 16860167
[TBL] [Abstract][Full Text] [Related]
60. Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial.
Baker JF; Schumacher HR; Krishnan E
Angiology; 2007; 58(4):450-7. PubMed ID: 17875958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
